Bausch Health Companies (TSE:BHC) Shares Down 2.3% – Should You Sell?

Shares of Bausch Health Companies Inc. (TSE:BHC) were down 2.3% during mid-day trading on Thursday . The stock traded as low as C$10.02 and last traded at C$10.11. Approximately 523,547 shares changed hands during mid-day trading, an increase of 16% from the average daily volume of 451,074 shares. The stock had previously closed at C$10.35.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Raymond James Financial upgraded Bausch Health Companies to a “hold” rating in a report on Monday, December 15th. Barclays upgraded Bausch Health Companies to a “hold” rating in a research note on Monday, December 8th. Two investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Bausch Health Companies presently has an average rating of “Hold”.

Bausch Health Companies Price Performance

The company has a current ratio of 1.19, a quick ratio of 0.58 and a debt-to-equity ratio of -1,831.94. The stock has a market cap of C$3.61 billion, a PE ratio of 10.03, a PEG ratio of 0.21 and a beta of 0.54. The business has a 50-day moving average price of C$9.57 and a 200 day moving average price of C$9.39.

Bausch Health Companies (TSE:BHC) last announced its quarterly earnings data on Wednesday, October 29th. The company reported C$0.48 earnings per share for the quarter. Bausch Health Companies had a positive return on equity of 15.87% and a negative net margin of 1.88%.The company had revenue of C$2.68 billion during the quarter. As a group, research analysts forecast that Bausch Health Companies Inc. will post 5.5472637 earnings per share for the current fiscal year.

Bausch Health Companies Company Profile

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.